SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-065914
Filing Date
2024-05-29
Accepted
2024-05-29 16:05:10
Documents
12
Period of Report
2024-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atha-20240523.htm   iXBRL 8-K 61750
2 EX-3.1 atha-ex3_1.htm EX-3.1 8263
  Complete submission text file 0000950170-24-065914.txt   192026

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20240523.xsd EX-101.SCH 27170
15 EXTRACTED XBRL INSTANCE DOCUMENT atha-20240523_htm.xml XML 4888
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 24998308
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)